Unknown

Dataset Information

0

A novel liver-specific fluorescent anti-cancer drug delivery system using indocyanine green.


ABSTRACT: Indocyanine green (ICG) accumulates only in hepatocytes and their malignant counterpart, hepatocellular carcinoma (HCC). We have developed ICG-conjugated anti-cancer drugs and noted their significant accumulation in HCC cells both in vitro and in vivo. ICG-conjugated gemcitabine was less toxic to normal cells and it had superior anti-tumor action compared to gemcitabine alone in a subcutaneous tumor xenograft. ICG conjugation can provide a novel fluorescent drug delivery system for treatment of liver cancer and this system can be used to both diagnose and treat HCC.

SUBMITTER: Inagaki Y 

PROVIDER: S-EPMC6395603 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel liver-specific fluorescent anti-cancer drug delivery system using indocyanine green.

Inagaki Yoshinori Y   Kokudo Takashi T   Kamiya Mako M   Uno Shin-Nosuke SN   Sato Masumitsu M   Kaneko Junichi J   Kokudo Norihiro N   Urano Yasuteru Y   Hasegawa Kiyoshi K  

Scientific reports 20190228 1


Indocyanine green (ICG) accumulates only in hepatocytes and their malignant counterpart, hepatocellular carcinoma (HCC). We have developed ICG-conjugated anti-cancer drugs and noted their significant accumulation in HCC cells both in vitro and in vivo. ICG-conjugated gemcitabine was less toxic to normal cells and it had superior anti-tumor action compared to gemcitabine alone in a subcutaneous tumor xenograft. ICG conjugation can provide a novel fluorescent drug delivery system for treatment of  ...[more]

Similar Datasets

| S-EPMC4332816 | biostudies-literature
| S-EPMC9086377 | biostudies-literature
| S-EPMC4780723 | biostudies-literature
| S-EPMC7750833 | biostudies-literature
| S-EPMC9165200 | biostudies-literature
| S-EPMC7422759 | biostudies-literature
| S-EPMC8848388 | biostudies-literature
| S-EPMC5452655 | biostudies-other
| S-EPMC7673564 | biostudies-literature